Recognized leaders in their medical specialties
Dr. Patrick McCarthy is the Executive Director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. He is internationally recognized for his expertise in mitral valve repair, having performed over 5,000 such procedures with exceptional outcomes.
Northwestern Memorial Hospital's cardiovascular program is consistently ranked among the top in the nation, offering cutting-edge treatments including minimally invasive valve procedures, complex coronary artery bypass grafting, and advanced heart failure therapies. The hospital is a pioneer in transcatheter aortic valve replacement (TAVR) and has one of the largest left ventricular assist device (LVAD) programs in the country.
Dr. Eric Topol is a world-renowned cardiologist and genomic researcher who serves as Executive Vice President at Scripps Research. He has pioneered the use of wireless and smartphone technology in healthcare, founding the Scripps Research Translational Institute which focuses on individualized medicine.
Scripps Research is at the forefront of integrating technology with medicine, offering innovative cardiovascular care that includes personalized treatment plans based on genetic testing, advanced imaging techniques, and remote patient monitoring. The institution is known for its groundbreaking research in digital biomarkers and AI applications in cardiology.
Dr. Deepak Bhatt serves as Executive Director of Interventional Cardiovascular Programs at Brigham and Women's Hospital. He has led numerous landmark clinical trials that have shaped modern cardiovascular practice, particularly in the areas of antiplatelet therapy and lipid management.
Brigham and Women's Hospital is consistently ranked among the top cardiovascular centers in the U.S., offering comprehensive services from preventive cardiology to complex interventions. The hospital is renowned for its expertise in chronic total occlusion (CTO) percutaneous coronary intervention, structural heart interventions, and advanced imaging-guided procedures.
Dr. Robert Spetzler is Director Emeritus of the Barrow Neurological Institute and one of the world's most respected neurosurgeons. He has pioneered numerous surgical techniques for treating complex brain aneurysms and arteriovenous malformations (AVMs), including the revolutionary "cardiac standstill" procedure.
Barrow Neurological Institute is one of the largest and most comprehensive neuroscience centers in the world, with particular expertise in cerebrovascular disorders, brain tumors, and spinal conditions. The institute performs more brain aneurysm surgeries than any other facility in the United States and has developed innovative minimally invasive techniques for treating these conditions.
Dr. Keith Black is Chairman of Neurosurgery at Cedars-Sinai Medical Center and a world-renowned expert in brain tumor treatment. His groundbreaking research focuses on developing methods to overcome the blood-brain barrier to deliver chemotherapy more effectively to brain tumors.
Cedars-Sinai's Department of Neurosurgery is at the forefront of brain tumor treatment, offering advanced surgical techniques including awake craniotomies, laser ablation, and novel immunotherapy approaches. The hospital's Brain Tumor Center provides comprehensive care from diagnosis through treatment and rehabilitation, with particular expertise in glioblastoma and metastatic brain tumors.
Dr. Steven Rosenberg is Chief of Surgery at the National Cancer Institute and a pioneer in cancer immunotherapy. He developed the first effective immunotherapies for selected patients with advanced cancer, including adoptive cell transfer using tumor-infiltrating lymphocytes (TILs).
The National Cancer Institute's Surgery Branch is at the forefront of developing innovative immunotherapies for cancer, with particular expertise in treating melanoma, sarcoma, and gastrointestinal cancers. The institute offers cutting-edge treatments including genetically engineered T-cell therapies, checkpoint inhibitors, and personalized cancer vaccines.
Dr. Patrick Hwu is the President and CEO of MD Anderson Cancer Center and a leading expert in tumor immunology. His research focuses on overcoming immune resistance in the tumor microenvironment, and he has been instrumental in developing novel combination immunotherapies.
MD Anderson Cancer Center is consistently ranked as the top cancer hospital in the United States, offering comprehensive cancer care across all specialties. The institution is particularly renowned for its melanoma and sarcoma programs, which integrate cutting-edge immunotherapies, targeted therapies, and innovative surgical approaches.
Dr. Monica Bertagnolli is a renowned surgical oncologist specializing in gastrointestinal cancers and former Director of the Dana-Farber Cancer Institute. She has led numerous national clinical trials investigating new treatments for colorectal and other gastrointestinal cancers.
Dana-Farber Cancer Institute is a world leader in cancer treatment and research, with particular strengths in gastrointestinal oncology, hematologic malignancies, and breast cancer. The institute offers innovative treatments including minimally invasive surgical techniques, precision medicine approaches, and access to groundbreaking clinical trials.
Dr. Freddie Fu was the Chairman of Orthopedic Surgery at UPMC and a world-renowned expert in sports medicine and knee ligament reconstruction. He pioneered anatomic ACL reconstruction techniques that have become the gold standard worldwide.
UPMC's Department of Orthopedic Surgery is consistently ranked among the top programs in the nation, with particular expertise in sports medicine, joint preservation, and complex joint reconstruction. The hospital offers cutting-edge treatments including biologic approaches to cartilage repair, minimally invasive joint replacement, and advanced rehabilitation protocols.
Dr. James Andrews is one of the most famous orthopedic surgeons in the world, specializing in sports medicine and the treatment of professional athletes. He has treated countless elite athletes across all major sports and is particularly known for his expertise in Tommy John elbow reconstruction.
The Andrews Institute is a world-class center for orthopedic and sports medicine, offering comprehensive care from injury prevention to rehabilitation. The facility features state-of-the-art diagnostic equipment, minimally invasive surgical techniques, and specialized programs for baseball players, gymnasts, and other athletes at high risk for specific injuries.
Dr. John Waldhausen is Chief of Pediatric General and Thoracic Surgery at Seattle Children's Hospital. He specializes in minimally invasive surgical techniques for children and has particular expertise in congenital diaphragmatic hernia repair and chest wall deformities.
Seattle Children's Hospital is consistently ranked among the top pediatric hospitals in the nation, with a comprehensive pediatric surgery program that includes specialized centers for fetal care, neonatal surgery, and complex congenital conditions. The hospital is a leader in developing and implementing minimally invasive techniques for pediatric patients.
Dr. Alan Flake is Director of the Center for Fetal Research at Children's Hospital of Philadelphia (CHOP) and a pioneer in fetal surgery. He developed the revolutionary "artificial womb" technology that could transform care for extremely premature infants.
CHOP's Center for Fetal Diagnosis and Treatment is one of the most advanced fetal care centers in the world, offering innovative procedures to treat conditions before birth. The hospital specializes in complex fetal interventions including twin-twin transfusion syndrome treatment, spina bifida repair, and congenital diaphragmatic hernia management.
Dr. Thomas Starzl was the "father of transplantation" who performed the world's first successful liver transplant at UPMC. His pioneering work in immunosuppression revolutionized organ transplantation and made it a viable treatment option for thousands of patients.
UPMC's Thomas E. Starzl Transplantation Institute continues his legacy as one of the world's foremost transplant centers, performing more than 600 organ transplants annually. The hospital specializes in complex pediatric and adult liver, kidney, pancreas, intestine, and multivisceral transplants, with particular expertise in living donor transplantation.
Dr. Dorry Segev is a transplant surgeon and epidemiologist at Johns Hopkins who has revolutionized kidney transplantation for HIV-positive patients. He developed protocols that allow safe organ transplantation between HIV-positive donors and recipients, significantly expanding the donor pool.
Johns Hopkins Comprehensive Transplant Center is one of the most active and innovative transplant programs in the world, performing all types of solid organ transplants with exceptional outcomes. The hospital is particularly known for its living donor kidney program, incompatible transplant protocols, and research into transplant tolerance.
Dr. Jean Emond is Chief of Transplant Surgery at NewYork-Presbyterian/Columbia and a world leader in living donor liver transplantation. He has developed innovative techniques to expand living donor liver transplantation while minimizing risks to donors.
NewYork-Presbyterian's Center for Liver Disease and Transplantation is one of the most experienced living donor liver transplant programs in the United States, performing over 100 such procedures annually. The center specializes in complex liver transplants including those for metabolic diseases, hepatocellular carcinoma, and acute liver failure.
Dr. Jeffrey Saver is Director of the UCLA Comprehensive Stroke Center and a leading researcher in acute stroke treatment. He has played key roles in developing modern stroke therapies including thrombolysis and thrombectomy, and has led numerous landmark clinical trials.
UCLA's Comprehensive Stroke Center is one of the nation's top programs for stroke care and research, offering 24/7 access to advanced treatments including mechanical thrombectomy, neurocritical care, and cutting-edge rehabilitation. The center specializes in treating complex strokes and developing new interventions to protect the brain during stroke.
Dr. Helen Mayberg is a neurologist and pioneer in using deep brain stimulation (DBS) to treat severe depression. Her groundbreaking research identified Area 25 in the brain as a key regulator of mood and target for depression treatment.
Mount Sinai's Depression and Anxiety Center for Discovery and Treatment is at the forefront of developing innovative therapies for treatment-resistant depression. The hospital offers comprehensive psychiatric care including DBS, transcranial magnetic stimulation (TMS), ketamine infusion therapy, and personalized medication approaches based on brain imaging.
Dr. Reza Dana is Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear and a world-renowned expert in corneal diseases and dry eye syndrome. His research has transformed our understanding of ocular surface inflammation and led to new treatments for these conditions.
Massachusetts Eye and Ear is one of the world's premier eye care centers, with particular expertise in corneal transplantation, ocular surface reconstruction, and complex anterior segment surgery. The hospital offers cutting-edge treatments including artificial cornea transplantation (Boston KPro), stem cell therapy for ocular surface disease, and novel dry eye therapies.
Dr. Julia Haller is Ophthalmologist-in-Chief at Wills Eye Hospital and a leading retina specialist. She has been at the forefront of developing new treatments for age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases.
Wills Eye Hospital is one of the nation's top eye care centers, with particular expertise in retinal diseases, cataract surgery, and oculoplastic procedures. The hospital's retina service offers cutting-edge treatments including anti-VEGF injections, retinal laser procedures, vitrectomy surgery, and participation in clinical trials of novel therapies.
Dr. Alfredo Sadun is a world-renowned neuro-ophthalmologist specializing in disorders of the optic nerve, including glaucoma and mitochondrial optic neuropathies. His research has advanced our understanding of how the optic nerve is affected in various diseases.
Doheny Eye Institute is a leader in neuro-ophthalmology and complex eye diseases, with particular expertise in optic nerve disorders, unexplained vision loss, and hereditary eye diseases. The institute offers comprehensive diagnostic services including advanced imaging techniques and specialized electrophysiologic testing.
Dr. Frank Lista is Medical Director of The Plastic Surgery Clinic and a pioneer in breast reconstruction techniques. He has developed innovative approaches to breast reconstruction after mastectomy that preserve sensation and create more natural-looking results.
The Plastic Surgery Clinic is renowned for its breast reconstruction and aesthetic surgery programs, offering state-of-the-art procedures including DIEP flap breast reconstruction, lymphatic microsurgery for lymphedema, and advanced body contouring techniques. The facility combines surgical excellence with comprehensive patient care and support services.
Dr. Rod Rohrich is a world-renowned plastic surgeon specializing in rhinoplasty and facial rejuvenation. He has helped establish safety standards for cosmetic surgery worldwide and is considered one of the foremost experts in nasal surgery.
The Dallas Plastic Surgery Institute is a leader in aesthetic and reconstructive plastic surgery, with particular expertise in primary and revision rhinoplasty, facelift techniques, and non-surgical facial rejuvenation. The institute emphasizes evidence-based approaches to plastic surgery and has contributed significantly to the scientific literature in the field.
Dr. Alexandra Golant is Director of Dermatology at Mount Sinai and a leading expert in psoriasis and biologic therapies. She has been at the forefront of developing personalized treatment approaches for psoriasis and other immune-mediated skin diseases.
Mount Sinai's Department of Dermatology is renowned for its psoriasis and phototherapy center, offering comprehensive care including narrowband UVB, excimer laser, and the latest biologic medications. The department specializes in complex dermatologic conditions and has particular expertise in treating skin manifestations of systemic diseases.
Dr. Murad Alam is Vice Chair of Dermatology at Northwestern and a leader in minimally invasive cosmetic procedures and skin cancer surgery. He has developed innovative techniques in Mohs micrographic surgery that improve outcomes while minimizing scarring.
Northwestern's Dermatology Department is a leader in both medical and cosmetic dermatology, with particular expertise in Mohs surgery for skin cancer, laser treatments, and minimally invasive facial rejuvenation. The department offers comprehensive skin cancer screening and treatment programs, as well as cutting-edge cosmetic procedures.
Dr. Susan Taylor is Founding Director of the Skin of Color Center at University of Pennsylvania and a leading expert in dermatologic conditions affecting people of color. She has pioneered research into ethnic skin and hair disorders and developed specialized treatment approaches.
The University of Pennsylvania's Skin of Color Center is the first of its kind at a major academic medical center, offering specialized care for pigmentation disorders, hair loss in women of color, and skin conditions that disproportionately affect ethnic populations. The center combines clinical care with research and education to advance the field of ethnic dermatology.
Dr. Mark Pimentel is Executive Director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai and a leading expert in irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO). His research has revolutionized our understanding of these conditions.
Cedars-Sinai's MAST Program is at the forefront of research into the gut microbiome and its role in digestive disorders. The program offers specialized testing and treatment for IBS, SIBO, and other functional gastrointestinal disorders, including novel antibiotic and dietary approaches. The hospital is also a leader in advanced endoscopic procedures.
Dr. David Brenner is Vice Chancellor for Health Sciences at UC San Diego and a leading researcher in liver fibrosis and cirrhosis. His work has advanced our understanding of how liver cells become activated during injury and how this process might be reversed.
UC San Diego's Liver Center is renowned for its comprehensive approach to liver diseases, offering specialized programs for hepatitis, fatty liver disease, cirrhosis, and liver cancer. The center provides cutting-edge treatments including non-invasive fibrosis assessment, clinical trials of novel antifibrotic drugs, and minimally invasive procedures for liver conditions.
Dr. Daniel Drucker is a senior scientist at Mount Sinai Hospital and one of the world's leading diabetes researchers. His work on incretin hormones led to the development of GLP-1 receptor agonists, revolutionizing diabetes treatment.
Mount Sinai's Diabetes Center is at the forefront of diabetes care and research, offering comprehensive services including insulin pump therapy, continuous glucose monitoring, and specialized clinics for type 1 diabetes, type 2 diabetes, and diabetes in pregnancy. The center participates in clinical trials of novel diabetes medications and technologies.
Dr. Shlomo Melmed is Executive Vice President of Academic Affairs at Cedars-Sinai and a world-renowned expert in pituitary disorders. His research has led to new treatments for acromegaly, Cushing's disease, and prolactinomas.
Cedars-Sinai's Pituitary Center is one of the most experienced in the world, offering comprehensive care for all pituitary disorders including innovative medical therapies, minimally invasive transsphenoidal surgery, and stereotactic radiosurgery. The center specializes in complex cases and has particular expertise in treating pituitary tumors in pregnancy.
Dr. Aaron Cypess is a senior investigator at the Joslin Diabetes Center and a leading researcher in brown adipose tissue (brown fat) and its potential role in treating obesity and diabetes. His work has advanced our understanding of how brown fat can be activated to burn calories.
The Joslin Diabetes Center is world-renowned for its comprehensive diabetes care and research, offering specialized programs for type 1 diabetes, type 2 diabetes, diabetes technology, and diabetes complications. The center provides cutting-edge treatments including artificial pancreas systems, islet cell transplantation, and personalized diabetes management plans.